Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assay of heparin in plasma using a chromogenic substrate for activated factor X.

× No keyword cloud information.

25 in total

1. Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels.

Authors: Nusrat A Motlekar; Kalkunte S Srivenugopal; Mitchell S Wachtel; Bi-Botti C Youan
Journal: J Drug Target Date: 2005-12 Impact factor: 5.121

2. Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi.

Authors: Peter Hellstern; Juergen Bach; Melanie Simon; Werner Saggau
Journal: J Extra Corpor Technol Date: 2007-06

3. Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate.

Authors: Mohammad Warda; Robert J Linhardt
Journal: Comp Biochem Physiol B Biochem Mol Biol Date: 2005-11-17 Impact factor: 2.231

4. Investigations on plasma activity of low molecular weight heparin after intravenous and oral administrations.

Authors: M Dryjski; D E Schneider; P Mojaverian; B S Kuo; T D Bjornsson
Journal: Br J Clin Pharmacol Date: 1989-08 Impact factor: 4.335

5. Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation.

Authors: Nusrat Abbas Motlekar; Kalkunte Srirangachar Srivenugopal; Mitchell S Wachtel; Bi-Botti Celestin Youan
Journal: J Pharm Pharmacol Date: 2006-05 Impact factor: 3.765

6. [Prevention of thromboembolism with low-dose heparin].

Authors: J Kussmann
Journal: Langenbecks Arch Chir Date: 1986

7. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.

Authors: Nusrat A Motlekar; Alessio Fasano; Mitchell S Wachtel; Bi-Botti C Youan
Journal: J Drug Target Date: 2006-06 Impact factor: 5.121

8. Prospective randomized clinical study in general surgery comparing a new low molecular weight heparin with unfractionated heparin in the prevention of thrombosis.

Authors: J Limmer; D Ellbrück; H Müller; E Eisele; J Rist; F Schütze; H Beger; H Heimpel; E Seifried
Journal: Clin Investig Date: 1994-11

9. Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer.

Authors: Nusrat A Motlekar; Kalkunte S Srivenugopal; Mitchell S Wachtel; Bi-Botti C Youan
Journal: Drug Dev Res Date: 2006-02 Impact factor: 4.360

10. The effects of low-dose heparin treatment on patients undergoing transvesical prostatectomy.

Authors: P O Hedlund; M Blombäck
Journal: Urol Res Date: 1981